Anterix (ATEX) Expected to Release Quarterly Earnings on Tuesday

Key Points

• Anterix is expected to report Q2 2027 results after Tuesday’s market close, with analysts forecasting a loss of $0.2952 per share and revenue of approximately $2.05 million. The earnings call is scheduled for Wednesday, November 11, 2026.
• In its prior quarter, Anterix reported EPS of $0.01, beating the consensus estimate of a $0.43 loss, while revenue of $1.96 million fell slightly short of expectations.
• The stock recently traded near $82.10, while analysts maintain a “Moderate Buy” consensus rating and an average price target of $120.00; however, insiders sold more than 124,000 shares worth about $11 million over the past quarter.

Anterix (NASDAQ:ATEX - Get Free Report) is expected to announce its Q2 2027 results after the market closes on Tuesday, November 10th. Analysts expect Anterix to announce earnings of ($0.2952) per share and revenue of $2.05 million for the quarter. Investors may review the information on the company's upcoming Q2 2027 earnings summary page for the latest details on the call scheduled for Wednesday, November 11, 2026 at 9:00 AM ET.

Anterix (NASDAQ:ATEX - Get Free Report) last posted its quarterly earnings results on Tuesday, August 11th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.44. The company had revenue of $1.96 million for the quarter, compared to analyst estimates of $2.00 million. Anterix had a net margin of 933.03% and a negative return on equity of 10.65%. On average, analysts expect Anterix to post ($2.00) EPS for the current fiscal year and ($2.01) EPS for the next fiscal year.

Anterix Price Performance

Shares of NASDAQ ATEX traded down $0.11 during trading hours on Tuesday, reaching $82.10. The stock had a trading volume of 80,713 shares, compared to its average volume of 369,616. The business's fifty day moving average is $83.48 and its two-hundred day moving average is $65.40. The company has a market cap of $1.61 billion, a price-to-earnings ratio of 23.60 and a beta of 0.89. Anterix has a twelve month low of $17.58 and a twelve month high of $113.00.

Analyst Ratings Changes

Several equities research analysts have recently commented on ATEX shares. JPMorgan Chase & Co. reduced their target price on shares of Anterix from $133.00 to $130.00 and set an "overweight" rating on the stock in a research note on Thursday, August 13th. DA Davidson set a $161.00 price target on shares of Anterix in a report on Friday, August 21st. Wall Street Zen lowered shares of Anterix from a "hold" rating to a "sell" rating in a research report on Saturday, August 15th. Clear Str upgraded shares of Anterix to a "strong-buy" rating in a research report on Monday, July 27th. Finally, Weiss Ratings lowered shares of Anterix from a "hold (c+)" rating to a "hold (c)" rating in a report on Monday, October 26th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Anterix has a consensus rating of "Moderate Buy" and a consensus price target of $120.00.

Insiders Place Their Bets

In other Anterix news, insider Gena L. Ashe sold 4,357 shares of the stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $85.44, for a total value of $372,262.08. Following the transaction, the insider directly owned 5,174 shares in the company, valued at approximately $442,066.56. This trade represents a 45.71% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Scott A. Lang sold 15,000 shares of the business's stock in a transaction on Monday, September 21st. The stock was sold at an average price of $80.00, for a total value of $1,200,000.00. Following the sale, the chief executive officer owned 26,470 shares of the company's stock, valued at approximately $2,117,600. The trade was a 36.17% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 124,841 shares of company stock valued at $10,975,765 over the last quarter. Company insiders own 40.05% of the company's stock.

About Anterix

Anterix Inc NASDAQ: ATEX develops and provides private wireless broadband solutions for critical infrastructure industries. The company's primary focus is enabling electric, gas, water and other utilities to deploy secure, resilient communications networks that support operational technology, grid modernization and other mission-critical applications.

Anterix primarily uses its licensed 900 MHz spectrum holdings to support private broadband networks. Its offerings include spectrum access and related wireless communications solutions designed to help utilities connect field equipment, sensors, control systems and mobile workforces.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.